Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Okan Avci

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Journal of Clinical Medicine|May 13, 2026
Pretreatment Lactate Dehydrogenase-to-Albumin Ratio and Clinical Outcomes in Extensive-Stage Small Cell Lung Cancer: A Multicenter Real-World StudyAhmet Unlu, Asim Armagan Aydin, Esra Sazimet Kars, et al.
Tumori|August 9, 2021
Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world studyIbrahim Cil, Ahmet Kucukarda, Muhammed Mustafa Atcı, et al.
Journal of Cancer Research and Clinical Oncology|January 12, 2021
Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) studyBurak Bilgin, Mehmet Ali Nahit Sendur, Sebnem Yucel, et al.
Anti-Cancer Drugs|June 15, 2022
The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group studyÖzlem Özdemir, Baha Zengel, Yaşar Yildiz, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Journal of Clinical Medicine|May 13, 2026
Pretreatment Lactate Dehydrogenase-to-Albumin Ratio and Clinical Outcomes in Extensive-Stage Small Cell Lung Cancer: A Multicenter Real-World StudyAhmet Unlu, Asim Armagan Aydin, Esra Sazimet Kars, et al.
Tumori|August 9, 2021
Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world studyIbrahim Cil, Ahmet Kucukarda, Muhammed Mustafa Atcı, et al.
Journal of Cancer Research and Clinical Oncology|January 12, 2021
Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) studyBurak Bilgin, Mehmet Ali Nahit Sendur, Sebnem Yucel, et al.
Anti-Cancer Drugs|June 15, 2022
The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group studyÖzlem Özdemir, Baha Zengel, Yaşar Yildiz, et al.
Pageof 3